AkzoNobel and Evonik form JV for chlorine/potassium hydroxide solution

21 July 2015

AkzoNobel and Evonik have joined forces to build and operate a new membrane electrolysis facility for potassium hydroxide solution and chlorine in Germany. Start-up is expected by the end of 2017.

The 50-50 JV involves the construction and operation of a dedicated plant at AkzoNobel’s existing site in Ibbenbüren. It will have a nameplate capacity of around 130,000t/yr of potassium hydroxide solution and 82,000t of chlorine. This will strengthen the leading market positions of both companies. Financial details were not disclosed.

AkzoNobel will take over commercialisation of chlorine and hydrogen at the new plant and will process these products directly at the Ibbenbüren site. Evonik will take over the potassium hydroxide solution for commercialisation and processing at its own site in Lülsdorf. This is where Evonik processes potassium hydroxide solution into potassium carbonate (potash).

< Previous article

Michelman takes home ‘Deal Maker of the Year’ award

Next article >

Huntsman forms partnership with Bang & Bonsomer